XTAPEN

This brand name is authorized in Nigeria.

Active ingredients

The drug XTAPEN contains one active pharmaceutical ingredient (API):

1
UNII Q42T66VG0C - PENICILLIN G
 

Benzylpenicillin is a beta-lactam antibiotic. It is bacteriocidal by inhibiting bacterial cell wall biosynthesis. Penicillin resistance can be mediated by alteration of penicillin binding proteins or development of beta-lactamases.

 
Read more about Benzylpenicillin

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-1563 Injection XTAPEN INJECTION INJ 1MEGA(1000000IU) 1 X 10vials 37 RNW-PP-169542 XTAPEN INJECTION CRYSTALLINE PENICILLIN INJ 1 MEGA penicillin A4-1563 Drugs Imported Products 1x10 vials Prescription Only Medicine (POM) 12/13/2022 CHUPET PHARMACEUTICAL COMPANY LIMITED, TAORIDI STREET SURULERE LAGOS SURULERE LAGOS 80341443 chupetcoy@yahoo.com CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD, NO. 47 FENGSHOU RD., SHIJIAZHUANG, CHINA, China 28/09/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J01CE01 Benzylpenicillin J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CE Beta-lactamase sensitive penicillins
Discover more medicines within J01CE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-1563

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.